hyoscine-n-butylbromide

DRUG4 trials

Sponsors

Changhai Hospital, Kocaeli University, Cairo University, Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Conditions

Abdominal CrampsBile Duct DiseasesCatheter Related Bladder DiscomfortERCPEndometrial CancerOvarian CancerPancreatic Diseases

Phase 1

4FMFES-PET Imaging of Endometrial and Ovarian Cancers

CompletedNCT04823065

Centre de recherche du Centre hospitalier universitaire de SherbrookeEndometrial Cancer, Ovarian Cancer

Start: 2018-09-01End: 2024-04-30Updated: 2024-05-13

Phase 3

Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)

CompletedNCT00731198

Changhai HospitalBile Duct Diseases, ERCP, Pancreatic Diseases

Start: 2008-08-31End: 2009-07-31Updated: 2010-09-08

Phase 4

Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis

Kocaeli UniversityAbdominal Cramps

Start: 2015-07-31End: 2016-08-31Target: 126Updated: 2015-07-30

Unknown Phase

Efﬁcacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.

CompletedNCT03513250

Cairo UniversityCatheter Related Bladder Discomfort

Start: 2018-05-30End: 2020-07-15Updated: 2022-01-13